These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16570010)

  • 1. Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation.
    Auffermann-Gretzinger S; Eger L; Bornhäuser M; Schäkel K; Oelschlaegel U; Schaich M; Illmer T; Thiede C; Ehninger G
    Transplantation; 2006 Mar; 81(6):866-73. PubMed ID: 16570010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Bonifazi F; Bandini G; Saunthararajah Y; Zagnoli A; Stanzani M; Falcioni S; Perrone G; Tura S; Baccarani M; Rondelli D
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):106-15. PubMed ID: 14750076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
    Boeck S; Hamann M; Pihusch V; Heller T; Diem H; Rolf B; Pihusch R; Kolb HJ; Pihusch M
    Bone Marrow Transplant; 2006 Jan; 37(1):57-64. PubMed ID: 16258529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
    Chan GW; Gorgun G; Miller KB; Foss FM
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
    Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic HLA mismatched/ haploidentical hematopoietic stem cell transplantation].
    Wu JY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):73-7. PubMed ID: 17650664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alemtuzumab depletes dendritic cells more effectively in blood than in skin: a pilot study in patients with chronic lymphocytic leukemia.
    Auffermann-Gretzinger S; Eger L; Schetelig J; Bornhäuser M; Heidenreich F; Ehninger G
    Transplantation; 2007 May; 83(9):1268-72. PubMed ID: 17496545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
    Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion.
    Levenga H; Woestenenk R; Schattenberg AV; Maas F; Jansen JH; Raymakers R; De Mulder PH; van de Wiel-van Kemenade E; Schaap N; de Witte T; Dolstra H
    Bone Marrow Transplant; 2007 Sep; 40(6):585-92. PubMed ID: 17637687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants.
    Morse MA; Rizzieri D; Stenzel TT; Hobeika AC; Vredenburgh JJ; Chao NJ; Clay TM; Mosca PJ; Lyerly HK
    J Hematother Stem Cell Res; 2002 Aug; 11(4):659-68. PubMed ID: 12201954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease.
    Lau J; Sartor M; Bradstock KF; Vuckovic S; Munster DJ; Hart DN
    Transplantation; 2007 Apr; 83(7):839-46. PubMed ID: 17460553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.
    Akpek G; Joseph R; Günay C; Kessler II; Shvartsbeyn M; Bhatnagar B; Aurelian L
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):529-37. PubMed ID: 23313704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution.
    Klangsinsirikul P; Carter GI; Byrne JL; Hale G; Russell NH
    Blood; 2002 Apr; 99(7):2586-91. PubMed ID: 11895797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
    Matthews K; Lim Z; Pearce L; Pagliuca A; Alejandro Madrigal J; Mufti GJ; Barber LD
    Br J Haematol; 2010 Jun; 149(6):879-89. PubMed ID: 20346011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease.
    Clark FJ; Freeman L; Dzionek A; Schmitz J; McMullan D; Simpson P; Mason J; Mahendra P; Craddock C; Griffiths M; Moss PA; Chakraverty R
    Transplantation; 2003 Jan; 75(2):221-5. PubMed ID: 12548127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.
    Rajasekar R; Mathews V; Lakshmi KM; Sellathamby S; George B; Viswabandya A; Daniel D; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):344-50. PubMed ID: 18275901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.